Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegberon vs Pegasys in HBeAg-positive chronic hepatitis B
CTR20140377Phase 3Completed
- Sponsor
- Tebao Biotech
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Tebao Biotech. Started Jul 2014; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20140377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140377.